Top

Indian Journal of Otolaryngology and Head & Neck Surgery

Published in:

29-08-2023 | Osteomyelitis | Original Article

Outcome of Total Surgical Debridement of Covid Associated Rhino-Orbito-Cerebral Mucormycosis Based on a New Surgical Staging System: A Cohort Study

Authors: Lekshmy R. Kurup, Harshita Singh, Shilpee Bhatia Sharma, Trichy Narayanan Janakiram

Published in: Indian Journal of Otolaryngology and Head & Neck Surgery | Issue 1/2024

Abstract

To propose a surgical staging system with management protocol for post-covid Rhino-orbito-cerebral mucormycosis (ROCM) with central skull base osteomyelitis. A prospective cohort study of a total of 193 post-covid ROCM patients was conducted between May 2021 and January 2022 at a tertiary care centre. Patients were assessed radiologically and staged from I to V. Follow up period was 16 months and the surgical outcome in terms of recurrent disease was assessed. A total of 193 patients (129 primary and 64 revision) were studied. Maxilla was found to be the epicenter of anterior disease (69.3%) and pterygoid wedge was noted to be the epicenter of posterior disease (85.6%). More than 65% of our patients, at the time of presentation, presented with involvement of the central skull base. Intracranial disease was noted in 13.9% of patients and the mortality rate was 6.2%. This staging system provides a systematic step-by-step protocol for the management of ROCM, with emphasis on meticulous disease clearance at the central skull base.

Rodriguez-Morales AJ, Sah R, Millan-Oñate J, Gonzalez A, Montenegro-Idrogo JJ, Scherger S, Franco-Paredes C, Henao-Martínez AF (2021) COVID-19 associated mucormycosis: the urgent need to reconsider the indiscriminate use of immunosuppressive drugs. Ther Adv Infect Dis 8:20499361211027064. https://doi.org/10.1177/20499361211027065CrossRefPubMedPubMedCentral

Alfishawy M, Elbendary A, Younes A, Negm A, Hassan WS, Osman SH, Nassar M, Elanany MG (2021) Diabetes mellitus and coronavirus disease (COVID-19) associated mucormycosis (CAM): a wake-up call from Egypt. Diabetes Metab Syndr 15(5):102195. https://doi.org/10.1016/j.dsx.2021.102195CrossRefPubMedPubMedCentral

Skiada A, Pavleas I, Drogari-Apiranthitou M (2020) Epidemiology and diagnosis of mucormycosis: an update. J Fungi 6:265. https://doi.org/10.3390/jof6040265CrossRef

Singh AK, Singh R, Joshi SR, Misra A (2021) Mucormycosis in COVID-19: a systematic review of cases reported worldwide and in India. Diabetes Metab Syndr: Clin Res Rev 15:102146. https://doi.org/10.1016/j.dsx.2021.05.019CrossRef

Watanabe A, So M, Mitaka H, Ishisaka Y, Takagi H, Inokuchi R, Iwagami M, Kuno T (2022) Clinical features and mortality of COVID-19-associated mucormycosis: a systematic review and meta-analysis. Mycopathologia 187(2–3):271–289. https://doi.org/10.1007/s11046-022-00627-8CrossRefPubMedPubMedCentral

Sen M, Honavar SG, Bansal R, Sengupta S, Rao R, Kim U, Sharma M, Sachdev M, Grover AK, Surve A, Budharapu A (2021) Epidemiology, clinical profile, management, and outcome of COVID-19-associated rhino-orbital-cerebral mucormycosis in 2826 patients in India-Collaborative OPAI-IJO Study on Mucormycosis in COVID-19 (COSMIC), Report 1. Indian J Ophthalmol 69(7):1670. https://doi.org/10.4103/ijo.IJO_1565_21CrossRefPubMedPubMedCentral

Hussain S, Salahuddin N, Ahmad I et al (1995) Rhinocerebral invasive mycosis: occurence in immunocompetent individuals. Eur J Radiol 20:151–155. https://doi.org/10.1016/0720-048X(95)00644-6CrossRefPubMed

Pelton RW, Peterson EA, Patel BC et al (2001) Successful treatment of rhino-orbital mucormycosis without exenteration: the use of multiple treatment modalities. Ophthalmic Plast Reconstr Surg 17:62–66CrossRefPubMed

Hosseini SMS, Borghei P (2005) Rhinocerebral mucormycosis: pathways of spread. Eur Arch Oto-Rhino-Laryngol 262:932–938. https://doi.org/10.1007/s00405-005-0919-0CrossRef

10.

Sannathimmappa MB, Nambiar V, Aravindakshan R (2022) Storm of a rare opportunistic life threatening mucormycosis among post COVID-19 patients: a tale of two pathogens. Int J Crit Illn Inj Sci 12:38. https://doi.org/10.4103/ijciis.ijciis_48_21CrossRefPubMedPubMedCentral

11.

Spellberg B, Edwards J Jr, Ibrahim A (2005) Novel perspectives on mucormycosis: pathophysiology, presentation, and management. Clin Microbiol Rev 18:556–569. https://doi.org/10.1128/cmr.18.3.556-569.2005CrossRefPubMedPubMedCentral

12.

Ibrahim AS, Spellberg B, Avanessian V et al (2005) Rhizopus oryzae adheres to, is phagocytosed by, and damages endothelial cells in vitro. Infect Immun 73:778–783. https://doi.org/10.1128/iai.73.2.778-783.2005CrossRefPubMedPubMedCentral

13.

Hendrickson RG, Olshaker J, Duckett O (1999) Rhinocerebral mucormycosis: a case of a rare, but deadly disease. J Emerg Med 17:641–645. https://doi.org/10.1016/S0736-4679(99)00053-0CrossRefPubMed

14.

Yohai RA, Bullock JD, Aziz AA et al (1994) Survival factors in rhino-orbital-cerebral mucormycosis. Surv Ophthalmol 39:3–22. https://doi.org/10.1016/S0039-6257(05)80041-4CrossRefPubMed

15.

Augustine HF, White C, Bain J (2017) Aggressive combined medical and surgical management of mucormycosis results in disease eradication in 2 pediatric patients. Plast Surg 25:211–217. https://doi.org/10.1177/2292550317716119CrossRef

16.

Sponsler TA, Sassani JW, Johnson LN et al (1992) Ocular invasion in mucormycosis. Surv Ophthalmol 36:345–350. https://doi.org/10.1016/0039-6257(92)90111-6CrossRefPubMed

17.

Pai V, Sansi R, Kharche R et al (2021) Rhino-orbito-cerebral mucormycosis: pictorial review. Insights Imaging 12:1–7. https://doi.org/10.1186/s13244-021-01109-zCrossRef

18.

Prabhu RM, Patel R (2004) Mucormycosis and entomophthoramycosis: a review of the clinical manifestations, diagnosis and treatment. Clin Microbiol Infect 10:31–47. https://doi.org/10.1111/j.1470-9465.2004.00843.xCrossRefPubMed

19.

Keshri A, Mathialagan A, Aishwarya A, Bhuskute G, Kanaujia V, Singh AK, Singh RK, Dhiman RK, Agarwal R (2023) Is mucormycosis the end? A comprehensive management of orbit in COVID associated rhino-orbital–cerebral mucormycosis: preserving the salvageable. Eur Arch Otorhinolaryngol 280:819–827. https://doi.org/10.1007/s00405-022-07620-3CrossRefPubMed

20.

Soni K, Das A, Sharma V et al (2022) Surgical & medical management of ROCM (Rhino-orbito-cerebral mucormycosis) epidemic in COVID-19 era and its outcomes–A tertiary care center experience. Med Mycol J 32:101238. https://doi.org/10.1016/j.mycmed.2021.101238CrossRef

21.

Cornely OA, Alastruey-Izquierdo A, Arenz D et al (2019) Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium. Lancet Infect Dis 19:e405–e421. https://doi.org/10.1016/S1473-3099(19)30312-3CrossRefPubMedPubMedCentral

22.

Honavar SG (2021) Code mucor: guidelines for the diagnosis, staging and management of rhino-orbito-cerebral mucormycosis in the setting of COVID-19. Indian J Ophthalmol 69:1361. https://doi.org/10.4103/ijo.IJO_1165_21CrossRefPubMedPubMedCentral

23.

Vaid N, Mishra P, Gokhale N et al (2021) A proposed grading system and experience of COVID-19 associated rhino orbito cerebral mucormycosis from an Indian Tertiary Care Center. Indian J Otolaryngol Head Neck Surg. https://doi.org/10.1007/s12070-021-02986-yCrossRefPubMedPubMedCentral

24.

Naik MN, Rath S (2022) The ROC staging system for COVID-related rhino-orbital-cerebral mucormycosis. In: Seminars in Ophthalmology, vol 37. Taylor & Francis, pp 279–283. Doi: https://doi.org/10.1080/08820538.2021.1946094

25.

Dan M (2011) Mucormycosis of the head and neck. Curr Infect Dis Rep 13:123–131. https://doi.org/10.1007/s11908-010-0162-8CrossRefPubMed

26.

Patel A, Kaur H, Xess I et al (2020) A multicentre observational study on the epidemiology, risk factors, management and outcomes of mucormycosis in India. Clin Microbiol Infect 26:944-e9. https://doi.org/10.1016/j.cmi.2019.11.021CrossRef

27.

Chamilos G, Lewis RE, Kontoyiannis DP (2008) Delaying amphotericin B–based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis. Clin Infect Dis 47:503–9. https://doi.org/10.1086/590004CrossRefPubMed

28.

Parsi K, Itgampalli RK, Vittal R et al (2013) Perineural spread of rhino-orbitocerebral mucormycosis caused by Apophysomyces elegans. Ann Indian Acad Neurol 16:414. https://doi.org/10.4103/0972-2327.116921CrossRefPubMedPubMedCentral

Title: Outcome of Total Surgical Debridement of Covid Associated Rhino-Orbito-Cerebral Mucormycosis Based on a New Surgical Staging System: A Cohort Study
Authors: Lekshmy R. Kurup
Harshita Singh
Shilpee Bhatia Sharma
Trichy Narayanan Janakiram
Publication date: 29-08-2023
Publisher: Springer India
Keywords: Osteomyelitis
Wound Debridement
Published in: Indian Journal of Otolaryngology and Head & Neck Surgery / Issue 1/2024
Print ISSN: 2231-3796
Electronic ISSN: 0973-7707
DOI: https://doi.org/10.1007/s12070-023-04151-z

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Outcome of Total Surgical Debridement of Covid Associated Rhino-Orbito-Cerebral Mucormycosis Based on a New Surgical Staging System: A Cohort Study

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2024

An Evaluation of Obstructive Sleep Apnea Patient’s Quality of life Following Continuous Positive Airway Pressure and Uvulopalatopharyngoplasty

Sudden Onset Auditory Neuropathy Spectrum Disorder: A Rare Case Report of Brown Vialetto Van Laere Syndrome

Auditory Brainstem Response in a Child with Mitochondrial Disorder–Leigh Syndrome

Rare Case of Squamous Cell Carcinoma of Midline Dorsum of Tongue: Diagnostic and Management Dilemma

Hypoglossal Nerve Palsy Misdiagnosed as Tongue Tumor: A Rare Case of Calcified Hypoglossal Schwannoma

Trans-Nasal Endoscopic Repair of CSF Rhinorrhea: An Institutional Experience